November 9-11, 2020 | Virtual Conference

CONNECT
+ SHARE

The virtual conference is over, but you can still access key sessions from the GRx+Biosims conference thanks to On-Demand.

AN ONLINE EXPERIENCE FOR GENERIC AND BIOSIMILAR MEDICINES PROFESSIONALS

GRx+Biosims 2020
is going virtual

The mission of providing America’s patients with access to the generic and biosimilar medicines they need remains our top priority. As this country faces the challenges of COVID-19, the importance of our mission comes into clearer focus – and the need to share knowledge and best practices has even greater urgency.

Due to public health and safety concerns related to the coronavirus (COVID-19) pandemic, we decided to web-stream the conference. The format may be new but will still allow you to participate in Q&A with speakers, engage with your peers and meet with exhibitors.

View Justification Toolkit

Conference Imagery

Connecting to learn + share solutions for the future

GRx+Biosims 2020 is the premier scientific and regulatory event for the U.S. generics and biosimilars industries, featuring timely programming relevant to technical, regulatory and policy professionals.

Top officials and subject-matter experts share their knowledge and best practices to enhance attendees’ understanding of how to succeed in generic and biosimilar development; the regulatory process and approvals: and the evolving policy landscape.

Speaker Highlights

The keynote speakers committed to GRx+Biosims 2020 are among our nation’s leading health regulators and authorities.

Sarah Yim, M.D.

Director
Office of Therapeutic Biologics and Biosimilars, CDER’s Office of New Drugs (OND), FDA

Alexandra (Alex) Pratt, M.D.

Chair of the Department of Critical Care
MedStar Washington Hospital Center

Gerald Dal Pan, M.D., MHS

Director
Office of Surveillance and Epidemiology (OSE), CDER, FDA

Dan Leonard

President and Chief Executive Officer
AAM

Michael Kopcha, PhD, RPh

Director
Office of Pharmaceutical Quality (OPQ), CDER, FDA

Stephen Hahn, M.D.

Commissioner
FDA

Scott Gottlieb, M.D.

Former Commissioner, FDA

Sally Choe, PhD

Director
Office of Generic Drugs (OGD), CDER, FDA

Patrizia Cavazzoni, M.D. 

Acting Center Director
CDER, FDA

Rob Brenner, M.D., MMM

President, Clinical Integration & Physician Enterprise
Valley Health System

Alex M. Azar, II

Secretary
United States Department of Health and Human Services

Donald Ashley, J.D.

Director
Office of Compliance (OC), CDER, FDA

Complex Workshop

Space is limited to the first 200 sign-ups! This special workshop will be held on Tuesday, November 10, 2020 and is available only to registered GRx+Biosims attendees and separate registration is required at no additional fee, so act now to hold your spot.

More Information

Attending the GRx+Biosims 2020 conference?

Networking is a big part of this event, and we’ve got all kinds of ready-to-use, simple-to-customize and easy-to-share content that will help you jumpstart your networking efforts.

grxbiosims-social-image

Virtual Conference FAQs 

Our meetings team is hard at work from home, putting together a fantastic event that will deliver an outstanding virtual conference experience.  Please use our list of FAQs to find answers to your immediate questions.

Learn More

Our Sponsors

PLATINUM SPONSOR

GENERAL SESSION SPONSOR

GOLD SPONSOR

Amneal

WELCOME GIFT SPONSOR

Apotex Logo

SILVER SPONSORS

HEALTH AND FITNESS SPONSOR

Sandoz

BREAKOUT SESSION SPONSOR

Lachman Consultants

PATRON SPONSORS

Dr. Reddy
Taro

PUBLICATION PARTNERS

GaBi Logo
GBI
Pharma Boardroom Logo
Skip to content